Skip to content
10-Q

Quarterly Report

FORMA THERAPEUTICS HOLDINGS, INC.

0000950170-21-004376

← back to feed
Filed
Nov 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 9, 2021 47.4M sh
Shares Diluted Q3 2021 · Sep 30, 2021 47.37M sh
Shares Diluted Q3 2021 · Sep 30, 2021 47.33M sh
Shares Diluted Q3 2021 · Sep 30, 2020 41.09M sh
Shares Diluted Q3 2021 · Sep 30, 2020 16.62M sh
Capex Q3 2021 · Sep 30, 2021 $3.72M
Capex Q3 2021 · Sep 30, 2020 $134K
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$108.59M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$83.1M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $87.25M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $282.69M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $79.87M
Stockholders Equity Q3 2021 · Sep 30, 2021 $542.83M
Stockholders Equity Q3 2021 · Jun 30, 2021 $579.4M
Stockholders Equity Q3 2021 · Mar 31, 2021 $616.47M
Stockholders Equity Q3 2021 · Dec 31, 2020 $648.24M
Stockholders Equity Q3 2021 · Sep 30, 2020 $415.6M
Stockholders Equity Q3 2021 · Jun 30, 2020 $438.5M
Stockholders Equity Q3 2021 · Mar 31, 2020 $28.77M
Stockholders Equity Q3 2021 · Dec 31, 2019 $18.25M
Current Liabilities Q3 2021 · Sep 30, 2021 $32.63M
Current Liabilities Q3 2021 · Dec 31, 2020 $31.7M
Total Liabilities Q3 2021 · Sep 30, 2021 $59.39M
Total Liabilities Q3 2021 · Dec 31, 2020 $32.73M
Current Assets Q3 2021 · Sep 30, 2021 $534.89M
Current Assets Q3 2021 · Dec 31, 2020 $654.45M
Total Assets Q3 2021 · Sep 30, 2021 $602.23M
Total Assets Q3 2021 · Dec 31, 2020 $680.97M
Eps Diluted Q3 2021 · Sep 30, 2021 −$0.91
Eps Diluted Q3 2021 · Sep 30, 2021 −$2.60
Eps Diluted Q3 2021 · Sep 30, 2020 −$0.67
Eps Diluted Q3 2021 · Sep 30, 2020 −$2.74
Eps Basic Q3 2021 · Sep 30, 2021 −$0.91
Eps Basic Q3 2021 · Sep 30, 2021 −$2.60
Eps Basic Q3 2021 · Sep 30, 2020 −$0.67
Eps Basic Q3 2021 · Sep 30, 2020 −$2.74
Sga Expense Q3 2021 · Sep 30, 2021 $12.75M
Sga Expense Q3 2021 · Sep 30, 2021 $35.09M
Sga Expense Q3 2021 · Sep 30, 2020 $7.46M
Sga Expense Q3 2021 · Sep 30, 2020 $22.84M
Rd Expense Q3 2021 · Sep 30, 2021 $30.68M
Rd Expense Q3 2021 · Sep 30, 2021 $88.61M
Rd Expense Q3 2021 · Sep 30, 2020 $24.78M
Rd Expense Q3 2021 · Sep 30, 2020 $68.5M
Net Income Q3 2021 · Sep 30, 2021 −$43.29M
Net Income Q3 2021 · Sep 30, 2021 −$122.84M
Net Income Q3 2021 · Jun 30, 2021 −$43.59M
Net Income Q3 2021 · Mar 31, 2021 −$35.96M
Net Income Q3 2021 · Sep 30, 2020 −$27.62M
Net Income Q3 2021 · Sep 30, 2020 −$41.83M
Net Income Q3 2021 · Jun 30, 2020 −$25.44M
Net Income Q3 2021 · Mar 31, 2020 $11.23M
Operating Income Q3 2021 · Sep 30, 2021 −$43.43M
Operating Income Q3 2021 · Sep 30, 2021 −$123.7M
Operating Income Q3 2021 · Sep 30, 2020 −$32.24M
Operating Income Q3 2021 · Sep 30, 2020 −$91.41M
Stock Issued Q3 2021 · Dec 15, 2020 795K sh